Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03 (Q84937685)
Jump to navigation
Jump to search
scientific article published on 04 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03 |
scientific article published on 04 September 2012 |
Statements
Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03 (English)
Gritta Janka-Schaub
Gabriele Escherich
Martin Zimmermann
CoALL study group
4 September 2012